One in two people will develop cancer in their lifetime. Given this startling fact, developing novel treatments to improve cancer survivability is vital.
Today, on the International Day of Women and Girls in Science 2024, we celebrate the importance of achieving gender equality at work and we recognize the role that women and girls play in science and technology.
In the first of my blog posts for the year, I thought I would reflect on 2023 for the microbiome field, and explore what the field’s future may hold.
Review by Claire Derlot Head of Programs for LBP Development & Manufacturing A few weeks back, Nadine, Richard, Adrien, and I had the pleasure of attending the Boston-based microbiome drug […]
Introduction South Korea has emerged as a leading hub for innovative microbiome research and development, with a thriving biopharmaceutical industry and cutting-edge research institutions. In this article, we will highlight […]
Last month, Microbiome Movement returned to Boston for its 8th Drug Development summit. With 2023’s multiple regulatory approvals for C. difficile microbiome treatments, the event set out to platform microbial-based […]
Introduction Last month, Biose industrie had the privilege of speaking at Microbiome Connect: Asia. The two-day congress took place in Seoul, Korea, and was attended by microbiome enthusiasts across academia […]
Aurillac, France, May 29th, 2023 Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, and SBT instruments, a […]
Biose Industries takes pride in showcasing its partners and drawing attention to the fantastic work they are doing. We sat down with Alveolus Bio with whom we are working to […]
The Pharmabiotics Conference & Partnering returned for 2023, bringing together cutting-edge microbiome researchers and drug developers. In the heart of Lyon 220 microbiome stakeholders gathered to explore key topics facing […]